Farcast

About:

Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.

Website: https://www.farcastbio.com

Twitter/X: farcastbio

Top Investors: Techstars, Alumni Ventures, Tata Capital, RA Capital Management, Accel

Description:

Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

Total Funding Amount:

$74.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)mitrabiotech.com

Founders:

Mallik Sundaram, Pradip Majumder

Number of Employees:

51-100

Last Funding Date:

2019-07-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai